Case Escalation Series
RELEASED DATE: November 13, 2026
EXPIRATION DATE: November 13, 2027

Copyright © 2026 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
PROGRAM CHAIR
Udhayvir Singh Grewal, MD GI/Neuroendocrine Medical Oncologist Winship Cancer Institute Assistant Professor of Medical Oncology Emory University School of Medicine Atlanta, Georgia
PROGRAM OVERVIEW
This Clinical Case Challenge activity addresses the complexities of treatment selection for advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs), with emphasis on the role of tumor biology, disease characteristics, and patient-specific factors in guiding individualized care. Through interactive, case-based scenarios, learners will evaluate key clinical considerations, including tumor grade, primary site, disease burden, and progression, to inform treatment decisions and identify patients who may benefit from referral to specialized centers. Case-based questions reinforce evidence-based decision-making and practical application in clinical practice.TARGET AUDIENCE
This educational activity will be designed to meet the educational needs of medical oncologists, radiation oncologists, nuclear medicine specialists, endocrinologists, advanced healthcare practitioners, nurses, and other healthcare practitioners (HCPs) involved in the multidisciplinary treatment of patients with GEP-NETs.LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:- Explain the considerations for treatment selection for advanced GEP-NETs, such as tumor biology and clinical traits, and referral criteria to expert centers
- Employ evidence-based strategies for sequencing targeted therapies to enhance patient outcomes in advanced GEP-NETs
- Utilize recent clinical trial data to inform use of novel therapies in practice for advanced GEP-NETs
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 0.25 ANCC contact hours.ACCME INNOVATION PARTNER DISCLAIMER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (eg, name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures |
| Udhayvir Singh Grewal, MD | Consulting fees: Boehringer Ingelheim and Exelixis. |
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:- Andrew Grzybowski, CEO of Med Learning Group, has nothing to disclose.
- Lauren Welch, COO of Med Learning Group, has nothing to disclose.
- Tom Bregartner, MBA, VP of Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
- Lisa Kuhns, PhD, Medical Director of Med Learning Group, has nothing to disclose.
- Nicole Longo, DO, FACOI, VP of Med/Sci Services and Learner Engagement of Med Learning Group, has nothing to disclose.
- Shannon Mutch MS, RN, OCN, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Ana Maria Albino, Associate Director, Programs and Training, for Med Learning Group, has nothing to disclose.
- Kristen Marks, Associate Manager, Programs and Logistics for Med Learning Group, has nothing to disclose.
- Nicholas Torres, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use. For CE questions, please contact Med Learning Group at [email protected] Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected] RELEASED DATE: November 13, 2026 EXPIRATION DATE: November 13, 2027
Copyright © 2026 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
PROGRAM CHAIR

Shagufta Shaheen, MD
Clinical Assistant Professor of Medicine (Oncology)
Well-Being Director and Associate Division Chief for Culture and Community
Department of Medicine/Stanford University School of Medicine
Stanford, California
PROGRAM OVERVIEW
This Clinical Case Challenge activity addresses the evolving treatment landscape for advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs), with emphasis on evidence-based strategies for sequencing targeted and emerging therapies to optimize patient outcomes. Through interactive, case-based scenarios, learners will apply current clinical guidelines and recent clinical trial evidence to individualize treatment selection and sequencing based on disease characteristics, prior therapies, and treatment response. Case-based questions reinforce practical decision-making and integrate novel therapies into clinical practice.
TARGET AUDIENCE
This educational activity will be designed to meet the educational needs of medical oncologists, radiation oncologists, nuclear medicine specialists, endocrinologists, advanced healthcare practitioners, nurses, and other healthcare practitioners (HCPs) involved in the multidisciplinary treatment of patients with GEP-NETs.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Explain the considerations for treatment selection for advanced GEP-NETs, such as tumor biology and clinical traits, and referral criteria to expert centers
- Employ evidence-based strategies for sequencing targeted therapies to enhance patient outcomes in advanced GEP-NETs
- Utilize recent clinical trial data to inform use of novel therapies in practice for advanced GEP-NETs
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 0.5 ANCC contact hours.
ACCME INNOVATION PARTNER DISCLAIMER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (eg, name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures |
| Shagufta Shaheen, MD | Consulting fees: Exelixis |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Andrew Grzybowski, CEO of Med Learning Group, has nothing to disclose.
- Lauren Welch, COO of Med Learning Group, has nothing to disclose.
- Tom Bregartner, MBA, VP of Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
- Lisa Kuhns, PhD, Medical Director of Med Learning Group, has nothing to disclose.
- Nicole Longo, DO, FACOI, VP of Med/Sci Services and Learner Engagement of Med Learning Group, has nothing to disclose.
- Sarah Milano, RN, MSN, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Ana Maria Albino, Associate Director, Programs and Training, for Med Learning Group, has nothing to disclose.
- Kristen Marks, Associate Manager, Programs and Logistics for Med Learning Group, has nothing to disclose.
- Nicholas Torres, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: November 13, 2026
EXPIRATION DATE: November 13, 2027

Copyright © 2026 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.